Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with breast cancer

Journal of Clinical Oncology

Volumn 34, Issue 4, 2016, Pages 321-328

  Wang, Shi Yi ^a   Long, Jessica B ^b   Killelea, Brigid K ^b   Evans, Suzanne B ^b   Roberts, Kenneth B ^b   Silber, Andrea ^b   Gross, Cary P ^b  

^a YALE UNIVERSITY   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; BREAST NEOPLASMS; CANCER REGISTRY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREOPERATIVE CARE; PROCEDURES; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; SEER PROGRAM; UNITED STATES;

EID: 84955492262     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.62.9741     Document Type: Article

References (41)

1. Wang SY, Virnig BA, Tuttle TM, et al: Variability of preoperative breast MRI utilization among older women with newly diagnosed early-stage breast cancer. Breast J 19:627-636, 2013
2. Killelea BK, Long JB, Chagpar AB, et al: Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer. Breast Cancer Res Treat 141:155-163, 2013
3. Solin LJ: Counterview: Pre-operative breast MRI (magnetic resonance imaging) is not recommended for all patients with newly diagnosed breast cancer. Breast 19:7-9, 2010
4. Sardanelli F: Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast 19:3-6, 2010
5. Hede K: Preoperative MRI in breast cancer grows contentious. J Natl Cancer Inst 101:1667-1669, 2009
6. Mann RM, Kuhl CK, Kinkel K, et al: Breast MRI: Guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307-1318, 2008
7. Brennan ME, Houssami N, Lord S, et al: Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: Systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 27:5640-5649, 2009
8. Houssami N, Turner R, Macaskill P, et al: An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 32:392-401, 2014
9. Amir E, Bedard PL, Ocaña A, et al: Benefits and harms of detecting clinically occult breast cancer. J Natl Cancer Inst 104:1542-1547, 2012
10. Fisher B: Role of science in the treatment of breast cancer when tumor multicentricity is present. J Natl Cancer Inst 103:1292-1298, 2011
11. Morrow M, Waters J, Morris E: MRI for breast cancer screening, diagnosis, and treatment. Lancet 378:1804-1811, 2011
12. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
13. Mandelblatt J: To screen or not to screen older women for breast cancer: A new twist on an old question or will we ever invest in getting the answers? J Clin Oncol 25:2991-2992, 2007
14. National Cancer Institute: SEER-Medicare: Brief description of the SEER-Medicare databse. http://healthservices.cancer.gov/seermedicare/overview/
15. Broët P, de la Rochefordière A, Scholl SM, et al: Contralateral breast cancer: Annual incidence and risk parameters. J Clin Oncol 13:1578-1583, 1995
16. Vichapat V, Garmo H, Holmqvist M, et al: Tumor stage affects risk and prognosis of contralateral breast cancer: Results from a large Swedish-population-based study. J Clin Oncol 30:3478-3485, 2012
17. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40:IV-19-IV-25, 2002 (suppl 8)
18. Elixhauser A, Steiner C, Harris DR, et al: Comorbidity measures for use with administrative data. Med Care 36:8-27, 1998
19. Austin PC: Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150-161, 2011
20. Austin PC: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083-3107, 2009
21. Austin PC: Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol 172:1092-1097, 2010
22. Normand ST, Landrum MB, Guadagnoli E, et al: Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores. J Clin Epidemiol 54:387-398, 2001
23. D'Agostino RB Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265-2281, 1998
24. Welch HG, Black WC: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find. Ann Intern Med 127:1023-1028, 1997
25. Nielsen M, Thomsen JL, Primdahl S, et al: Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814-819, 1987
26. Betsill WL Jr, Rosen PP, Lieberman PH, et al: Intraductal carcinoma: Long-term follow-up after treatment by biopsy alone. JAMA 239:1863-1867, 1978
27. Page DL, Dupont WD, Rogers LW, et al: Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 49:751-758, 1982
28. Zahl PH, Gøtzsche PC, Mæhlen J: Natural history of breast cancers detected in the Swedish mammography screening programme: A cohort study. Lancet Oncol 12:1118-1124, 2011
29. Nemoto T, Patel JK, Rosner D, et al: Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67:2079-2082, 1991
30. Hughes KS, Schnaper LA, Berry D, et al: Cancer and Leukemia Group B; Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004
31. Fischer U, Zachariae O, Baum F, et al: The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14:1725-1731, 2004
32. Kim JY, Cho N, Koo HR, et al: Unilateral breast cancer: Screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer. Radiology 267:57-66, 2013
33. Yi A, Cho N, Yang KS, et al: Breast cancer recurrence in patients with newly diagnosed breast cancer without and with preoperative MR Imaging: A matched cohort study. Radiology 276:695-705, 2015
34. Solin LJ, Orel SG, Hwang WT, et al: Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26:386-391, 2008
35. Ko ES, Han BK, Kim RB, et al: Analysis of the effect of breast magnetic resonance imaging on the outcome in women undergoing breast conservation surgery with radiation therapy. J Surg Oncol 107:815-821, 2013
36. Hwang N, Schiller DE, Crystal P, et al: Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: Its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 16:3000-3009, 2009
37. Morrow M: Magnetic resonance imaging in the breast cancer patient: Curb your enthusiasm. J Clin Oncol 26:352-353, 2008
38. Nichols HB, Berrington de González A, Lacey JV Jr, et al: Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564-1569, 2011
39. Kurian AW, McClure LA, John EM, et al: Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst 101:1058-1065, 2009
40. Houssami N, Ciatto S, Macaskill P, et al: Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248-3258, 2008
41. Yi M, Mittendorf EA, Cormier JN, et al: Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: Time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol 29:4654-4661, 2011